Advertisement

The Latest

The FDA's Psychopharmacologic Drugs Advisory Committee will consider whether to recommend approval for a psychedelic treatment for post-traumatic stress disorder. 

The Substance Abuse and Mental Health Services Administration launched a funding opportunity that will invest up to $1.48 billion to U.S. states and $63 million to tribes to combat the substance use crisis. 

Hyper-awareness of mental health conditions could be harming kids' well-being, researchers said in a May 6 report from The New York Times report. 

Despite a slow final quarter of 2023, investors expect mergers and acquisitions in the behavioral health sector to pick up in 2024. 

Advertisement